AVITA Medical (RCEL) EBITDA Margin (2018 - 2026)
AVITA Medical's (RCEL) quarterly EBITDA Margin came in at 11.31% in Q4 2025, up 4386.0% YoY from 0.25% in Q4 2024, and up 79.12% on a QoQ basis from 54.17% in Q3 2025.
AVITA Medical (RCEL) EBITDA Margin (2018 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 8 years of EBITDA Margin data on file, last reported at 11.31% in Q4 2025.
- Quarterly EBITDA Margin rose 4386.0% year-over-year to 11.31% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 29.24% (up 5933.0% YoY) and the FY2025 annual result came in at 59.4%, up 2918.0% from the prior year.
- EBITDA Margin rose to 11.31% in Q4 2025, from 54.17% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 11.31% in Q4 2025 to a low of 154.95% in Q1 2024.
- A 5-year average of 77.8% and a median of 68.28% in 2021 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2021 — EBITDA Margin surged 32902 bps — and 2024, when it plunged 6101 bps.
- Tracing RCEL's EBITDA Margin over 5 years: stood at 63.8% in 2021, then slumped by 64 bps to 104.71% in 2022, then grew by 17 bps to 86.46% in 2023, then jumped by 36 bps to 55.17% in 2024, then surged by 79 bps to 11.31% in 2025.
- The last three EBITDA Margin figures came in at 11.31% (Q4 2025), 54.17% (Q3 2025), and 61.17% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | AVITA Medical | 309.04 Mn | 297.90 Mn | 17.77 Mn | -31.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.59% |
| Dec 31, 2025 | -11.31% |
| Sep 30, 2025 | -54.17% |
| Jun 30, 2025 | -61.17% |
| Mar 31, 2025 | -64.54% |
| Dec 31, 2024 | -55.17% |
| Sep 30, 2024 | -70.63% |
| Jun 30, 2024 | -102.82% |
| Mar 31, 2024 | -154.95% |
| Dec 31, 2023 | -86.46% |
| Sep 30, 2023 | -68.20% |
| Jun 30, 2023 | -95.00% |
| Mar 31, 2023 | -93.94% |
| Dec 31, 2022 | -104.71% |
| Sep 30, 2022 | -63.22% |
| Mar 31, 2022 | -125.84% |
| Sep 30, 2021 | -63.80% |
| Jun 30, 2021 | -56.09% |
| Mar 31, 2021 | -68.35% |
| Dec 31, 2020 | -110.35% |